Volume 30, Number 7—July 2024
Research Letter
Emergence of Indigenous Dengue Fever, Niger, October 2023
Table
Variables | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 |
---|---|---|---|---|---|---|---|
Sex |
M |
M |
F |
F |
M |
F |
M |
Age, y |
40 |
13 |
47 |
28 |
51 |
45 |
16 |
Signs/symptoms |
Fever, headache, muscle pain |
Fever, headache, muscle pain |
Fever, headache, muscle pain |
Fever, headache, muscle pain, vomiting, vertigo |
Fever, headache, muscle pain, vomiting, asthenia |
Fever, headache, muscle pain |
Fever, muscle pain |
Mode of care |
Hospitalized |
Hospitalized |
Hospitalized |
Ambulatory |
Hospitalized |
Hospitalized |
Hospitalized |
Fever onset date |
2023 Oct 10 |
2023 Oct 19 |
2023 Oct 22 |
2023 Oct 21 |
2023 Oct 20 |
2023 Oct 23 |
2023 Oct 20 |
Sampling date |
2023 Oct 25 |
2023 Oct 25 |
2023 Oct 25 |
2023 Oct 27 |
2023 Oct 27 |
2023 Oct 27 |
2023 Oct 27 |
Dengue typing |
Positive |
Positive |
Positive |
Positive |
Positive |
Positive |
Positive |
Dengue serotyping | DENV-3 | DENV-3 | ND | DENV-1 | ND | ND | DENV-1 |
*DENV, dengue virus; ND, serotyping not done because of low viral load.
Page created: May 10, 2024
Page updated: June 22, 2024
Page reviewed: June 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.